Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review

T Bommersbach, M Justen, AM Bunting… - International Journal of …, 2023 - Elsevier
Background The majority of patients with opioid use disorder do not receive medications for
opioid use disorder (MOUD), especially in rural areas. The patient-centered access to …

Geographic information science and the United States opioid overdose crisis: A scoping review of methods, scales, and application areas

J Sauer, K Stewart - Social Science & Medicine, 2023 - Elsevier
Abstract Background The Opioid Overdose Crisis (OOC) continues to generate morbidity
and mortality in the United States, outpacing other prominent accident-related reasons …

Research priorities for expansion of opioid use disorder treatment in the community pharmacy

JB Jarrett, J Bratberg, AL Burns, G Cochran… - Substance …, 2023 - journals.sagepub.com
In the last decade, the US opioid overdose crisis has magnified, particularly since the
introduction of synthetic opioids, including fentanyl. Despite the benefits of medications for …

Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous US

S Amiri, V Panwala, O Amram - Journal of substance use and addiction …, 2024 - Elsevier
Background The burden of drug overdose mortality varies by race and ethnicity, with
American Indian/Alaska Native (AI/AN), Black, and White people experiencing the largest …

Accessibility of opioid treatment programs based on conventional vs perceived travel time measures

J Kim, J Lee, TA Thornhill, J Dennett, H Lu… - JAMA Network …, 2024 - jamanetwork.com
Importance Transportation barriers have long been associated with poorer health outcomes;
this burden is especially acute for individuals with opioid use disorder (OUD), a chronic …

Disparities in expected driving time to opioid treatment and treatment completion: findings from an exploratory study

A Alibrahim, JC Marsh, H Amaro, Y Kong… - BMC health services …, 2022 - Springer
Background Commuting time to treatment has been shown to affect healthcare outcomes
such as engagement and initiation. The purpose of this study is to extend this line of …

Geographic variation in availability of opioid treatment programs across US communities

S Jehan, WE Zahnd, NR Wooten… - Journal of addictive …, 2024 - Taylor & Francis
Abstract Methadone for Opioid Use Disorder (OUD) treatment is only dispensed at Opioid
Treatment Programs (OTPs). Little is known about the geographic variation in OTP …

[HTML][HTML] Implications of increased access to buprenorphine for medical providers in rural areas: a review of the literature and future directions

HM Gregory, VM Hill, RW Parker - Cureus, 2021 - ncbi.nlm.nih.gov
Abstract Buprenorphine/Naloxone (Suboxone®) is an efficacious treatment for opioid use
disorder (OUD) due to its more convenient dosing, superior safety profile, and decreased …

Deaths associated with opioids, race and ethnicity, and years of potential life lost in Washington State

S Amiri, CD Pham, S Castonguay, JT Denney… - Journal of Substance …, 2022 - Elsevier
Introduction This study examined disparities in years of potential life lost (YPLL) related to
opioid use among racial and ethnic groups adjusting for individual-and neighborhood-level …

Affordable transportation access to treatment for opioid use disorder

NS Ngo, K Anand - Transport Policy, 2024 - Elsevier
Transportation is a key barrier for accessing healthcare services. This is particularly
concerning for the millions suffering from opioid use disorder (OUD) since treatment for OUD …